Biosynthetic gene cluster of carrimycin
AssigneeShenyang Fuyang Pharmaceutical Technology Co., Ltd.
InventorsYiguang WANG, Yang JIANG, Xiaofeng ZHAO, Weiqing HE, Jianlu DAI
Life of this patent
Estimating the term…
Loading patent…
AssigneeShenyang Fuyang Pharmaceutical Technology Co., Ltd.
InventorsYiguang WANG, Yang JIANG, Xiaofeng ZHAO, Weiqing HE, Jianlu DAI
Estimating the term…
The present disclosure provides a biosynthetic gene cluster of carrimycin. The biosynthetic gene cluster comprises 44 gene open reading frames (orf), i.e., 5 orfs (orf10-14) encoding polyketide synthase, 9 orfs (orf1, 4-6, 15 and 36-39) related to polyketone synthesis extension unit and modification, 16 orfs (orf9, 16-22, 24, 26, 28, 29, 33-35 and 41) related to glycosyl synthesis, 6 orfs (orf7, 8, 30-32 and 40) related to glycosyl transfer, 2 orfs (orf3 and 25) related to resistance, 4 orfs (orf2, 23, 27 and 42) possibly related to regulation, a tsr resistance marker gene orf (orf43) and a 4″-mycaroseglucoside isovaleryl transferase gene orf (orf44).
A biosynthetic gene cluster of carrimycin, comprising 44 genes comprising:
Dependencies are inferred from the claim text.